Association between T102C and A-1438G polymorphisms in the serotonin receptor 2A (5-HT2A) gene and schizophrenia: Relevance for treatment with antipsychotic drugs

Clinical Chemistry and Laboratory Medicine

Volumn 45, Issue 7, 2007, Pages 835-838

  Peñas Lledó, Eva M ^a   Dorado, Pedro ^a   Cáceres, Macarena C ^a   De La Rubia, Alfredo ^b   Llerena, Adrián ^a,c  

^a UNIVERSITY OF EXTREMADURA   (Spain)

^b Hospital de Merida   (Spain)

^c HOSPITAL INFANTA CRISTINA   (Spain)

Author keywords

A 1438G polymorphism; Risperidone; Schizophrenia; Seretonin 2A receptor; T102C polymorphism

Indexed keywords

HALOPERIDOL; NEUROLEPTIC AGENT; RISPERIDONE; SEROTONIN 2A RECEPTOR; THIORIDAZINE;

ADULT; ARTICLE; CLINICAL TRIAL; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; FEMALE; GENE FREQUENCY; GENE LINKAGE DISEQUILIBRIUM; GENOTYPE; HETEROZYGOTE; HUMAN; MAJOR CLINICAL STUDY; MALE; MONOTHERAPY; PARANOIA; POLYMERASE CHAIN REACTION; PRIORITY JOURNAL; PROTEIN POLYMORPHISM; RESTRICTION FRAGMENT LENGTH POLYMORPHISM; SCHIZOPHRENIA;

ADULT; AGED; ANTIPSYCHOTIC AGENTS; FEMALE; GENE FREQUENCY; GENETIC PREDISPOSITION TO DISEASE; GENOTYPE; HUMANS; LINKAGE DISEQUILIBRIUM; MALE; MIDDLE AGED; POLYMORPHISM, GENETIC; RECEPTOR, SEROTONIN, 5-HT2A; RISPERIDONE; SCHIZOPHRENIA;

EID: 34447288445     PISSN: 14346621     EISSN: 14374331     Source Type: Journal    
DOI: 10.1515/CCLM.2007.181     Document Type: Article

References (31)

1. Roth BL, Meltzer HY. The role of serotonin in schizophrenia. In: Bloom FE, Kupfer DJ, editors. Psychopharmacology: the fourth generation of progress. New York, USA: Raven Press, 1995:1215-28.
2. Dean B. The cortical serotonin 2A receptor and the pathology of schizophrenia: a likely accomplice. J Neurochem 2003;85:1-13.
3. Li D, Duan Y, He L. Association study of serotonin 2A receptor (5-HT2A) gene with schizophrenia and suicidal behavior using systematic meta-analysis. Biochem Biophys Res Commun 2006;340:1006-15.
4. Hsieh CL, Bowcock AM, Farrer LA, Hebert JM, Huang KN, Cavilli-Sforza LL, et al. The serotonin receptor subtype 2 locus HTR2 is on human chromosome 13 near genes for esterase D and retinoblastoma-1 and on mouse chromosome 14. Somat Cell Mol Genet 1990;16:567-74.
5. Warren JT, Peacock ML, Rodriguez LC, Fink JK. An MspI polymorphism in the human serotonin receptor gene (HTR2): detection by DGGE and RFLP analysis. Hum Mol Genet 1993;2:338.
6. Williams J, Spurlock G, McGuffin P, Mallet J, Nothen MM, Gill M, et al. Association between schizophrenia and T102C polymorphism of the 5-hydroxytryptamine type 2a-receptor gene. European Multicentre Association Study of Schizophrenia (EMASS) Group. Lancet 1996;347:1294-6.
7. Clifford CP, Nunez DJ. 5HT 2a receptor T102C polymorphism and schizophrenia. Lancet 1996;347:1830.
8. Petronis A. The genes for major psychosis: aberrant sequence or regulation? Neuropsychopharmacology 2000;23:1-12.
9. Attwood JT, Yung RL, Richardson BC. DNA methylation and the regulation of gene transcription. Cell Mol Life Sci 2002;59:241-57.
10. Watson RE, Goodman JI. Effects of phenobarbital on DNA methylation in GC-rich regions of hepatic DNA from mice that exhibit different levels of susceptibility to liver tumorigenesis. Toxicol Sci 2002;68:51-8.
11. Arranz MJ, Munro J, Owen MJ. Evidence for association between polymorphisms in the promoter and coding regions of the 5HT2A receptor gene and response to clozapine. Mol Psychiatry 1998;3:61-6.
12. Parsons MJ, D'Souza UM, Arranz MJ, Kerwin RW, Makoff AJ. The -1438A/G polymorphism in the 5-hydroxytryptamine type 2A receptor gene affects promoter activity. Biol Psychiatry 2004;56:406-10.
13. Hoyer D, Pazos A, Probst A, Palacios JM. Serotonin receptors in the human brain. II. Characterization and autoradiographic localization of 5-HT1C and 5-HT2 recognition sites. Brain Res 1986;376:97-107.
14. Hirose A, Sasa M, Akaike A, Takaori S. Inhibition of hippocampal CA1 neurons by 5-hydroxytryptamine, derived from the dorsal raphe nucleus and the 5-hydroxytryptamine1A agonist SM-3997. Neuropharmacology 1990;29:93-101.
15. Jakab RL, Goldman-Rakic PS. 5-Hydroxytryptamine2A serotonin receptors in the primate cerebral cortex: possible site of action of hallucinogenic and antipsychotic drugs in pyramidal cell apical dendrites. Proc Natl Acad Sci USA 1998;95:735-40.
16. Willins DL, Deutch AY, Roth BL. Serotonin 5-HT2A receptors are expressed on pyramidal cells and interneurons in the rat cortex. Synapse 1997;27:79-82.
17. Nocjar C, Roth BL, Pehek EA. Localization of 5-HT(2A) receptors on dopamine cells in subnuclei of the midbrain A10 cell group. Neuroscience 2002;111:163-76.
18. LLerena A, Berecz R, Dorado P, de la Rubia A. QTc interval, CYP2D6 and CYP2C9 genotypes and risperidone plasma concentrations. J Psychopharmacol 2004;18:189-93.
19. Berecz R, de la Rubia A, Dorado P, Fernandez-Salguero P, Dahl ML, Llerena A. Thioridazine steady-state plasma concentrations are influenced by tobacco smoking and CYP2D6, but not by the CYP2C9 genotype. Eur J Clin Pharmacol 2003;59:45-50.
20. LLerena A, de la Rubia A, Berecz R, Dorado P. Relationship between haloperidol plasma concentration, debrisoquine metabolic ratio, CYP2D6 and CYP2C9 genotypes in psychiatric patients. Pharmacopsychiatry 2004;37:69-73.
21. Herken H, Erdal ME, Esgi K, Virit O, Aynacioglu AS. The relationship between the response to risperidone treatment and 5-HT2A receptor gene (T102C and 1438G/A) polymorphism in schizophrenia. Bull Clin Psychopharmacol 2003;13:161-6.
22. Abdolmaleky HM, Faraone SV, Glatt SJ, Tsuang MT. Meta-analysis of association between the T102C polymorphism of the 5HT2a receptor gene and schizophrenia. Schizophr Res 2004;67:53-62.
23. Mita T, Hanada S, Nishino N, Kuno T, Nakai H, Yamadori T, et al. Decreased serotonin S2 and increased dopamine D2 receptors in chronic schizophrenics. Biol Psychiatry 1986;21:1407-14.
24. Arora RC, Meltzer HY. Serotonin 2 (5-HT2) receptor binding in the frontal cortex of schizophrenic patients. J Neural Transm 1991;85:19-29.
25. Laruelle M, Abi-Dargham A, Casanova MF, Toti R, Weinberger DR, Kleinman JE. Selective abnormalities of prefrontal serotonergic receptors in schizophrenia. A postmortem study. Arch Gen Psychiatry 1993;50:810-8.
26. Burnet PW, Eastwood SL, Harrison PJ. 5-HT1A and 5-HT2A receptor mRNAs and binding site densities are differentially altered in schizophrenia. Neuropsychopharmacology 1996;15:442-55.
27. Meltzer HY. The role of serotonin in antipsychotic drug action. Neuropsychopharmacology 1999;21:106S-115S.
28. Chen RY, Sham P, Chen EY, Li T, Cheung EF, Cheung HK, et al. No association between T102C polymorphism of serotonin-2A receptor gene and clinical phenotypes of Chinese schizophrenic patients. Psychiatry Res 2001;105:175-85.
29. Joober R, Benkelfat C, Brisebois K, Toulouse A, Turecki G, Lal S, et al. T102C polymorphism in the 5HT2A gene and schizophrenia: relation to phenotype and drug response variability. J Psychiatry Neurosci 1999;24:141-6.
30. Lane HY, Chang YC, Chiu CC, Chen ML, Hsieh MH, Chang WH. Association of risperidone treatment response with a polymorphism in the 5-HT(2A) receptor gene. Am J Psychiatry 2002;159:1593-5.
31. Yamanouchi Y, Iwata N, Suzuki T, Kitajima T, Ikeda M, Ozaki N. Effect of DRD2, 5-HT2A, and COMT genes on antipsychotic response to risperidone. Pharmacogenomics J 2003;3:356-61.